New drug LY3985863 passes early safety check in healthy volunteers
NCT ID NCT07030127
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This early-stage study tested the safety and side effects of a new drug called LY3985863 in 24 healthy Chinese adults. Participants received multiple doses under the skin or a placebo, and researchers monitored for any adverse events. The goal was to see how the body processes the drug, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University Third Hospital
Beijing, 100191, China
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.